HC Wainwright & Co. Maintains Buy on Jasper Therapeutics, Lowers Price Target to $40

Benzinga57minutes ago · Ratings

Jasper Therapeutics Analyst Ratings

BenzingaJan 9 23:24 · Ratings

A Quick Look at Today's Ratings for Jasper Therapeutics(JSPR.US), With a Forecast Between $40 to $80

Futu NewsJan 9 21:00 · Ratings

RBC Cuts Price Target on Jasper Therapeutics to $48 From $68, Keeps Outperform, Speculative Risk

MT NewswiresJan 9 19:18 · Ratings

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaJan 9 05:06

Promising Efficacy and Safety of Jasper Therapeutics' Briquilimab Boosts Buy Rating

TipRanksJan 9 04:35 · Ratings